Nutrient Agar Substituted for Blood in Antibiograms
|
By LabMedica International staff writers Posted on 17 Sep 2012 |

Image: Antibiotic disc diffusion (Photo courtesy of The European Committee on Antimicrobial Susceptibility Testing).
In laboratories in the developed world, blood agar plates are used to test antibiotic sensitivity of bacteria, but in resource poor laboratories, this may not be feasible.
Beta-hemolytic Streptococcus species also grow on Standard Nutrient Agar 1 (StNA1 and it has been suggested this type of nutrient medium could be used for running agar diffusion tests.
Bacteriologists at Globolab eV Laboratory (Assling, Germany) conducted 103 comparative tests to evaluate the growth characteristics of beta-hemolytic Streptococcus spp. on StNA1 compared to Müller–Hinton agar supplemented with 5% sheep blood (B-MH). The specimens were obtained from patients admitted to a cooperating hospital in Germany and 16 beta-hemolytic streptococci strains were obtained.
Bacteria to be tested are streaked uniformly across a culture plate. Paper disks impregnated with eight different antibiotics (Oxoid; Wesel, Germany) to be tested are placed on the surface of the gelatinous agar. During incubation of the agar plate, the antibiotics diffuse from the disks into the surrounding agar. An effective agent will inhibit bacterial growth, and the size of such a zone of inhibition (ZoI) around the disk is measured. The relative effectiveness of a compound is determined by comparing the diameter of the ZoI with values in standard tables.
The authors found that found in 99 out of 103 (96.12%) of all cases that the absolute values of ZoI differences were smaller than or equal to 3 mm, and 92 out of 103 (89.32%) were smaller than or equal to 2 mm. The Standard Nutrient Agar 1 (StNA1) is marketed by Carl Roth GmbH (Karlsruhe, Germany) can be used for culturing Enterobacteriaceae, Pseudomonas spp., Staphylococcus spp., and Streptococcus spp. The B-MH used in the study was obtained from bioMérieux (Marcy l'Etoile, France).
The authors concluded that although blood agar is always the better choice for several reasons, the reading of the ZoI is often easier on StNA1 than on B-MH. This is because StNA1 is more transparent and, therefore, the edges between bacterial growth and the inhibition zone can be discerned more easily. In such places where no blood agar is available for conducting antibiograms, StNA1 is an appropriate substitute for blood-supplemented Müller–Hinton agar. The study was published on August 29, 2012, in the European Journal of Clinical Microbiology & Infectious Diseases.
Related Links:
Globolab e.V. Laboratory
Oxoid
Carl Roth GmbH
Beta-hemolytic Streptococcus species also grow on Standard Nutrient Agar 1 (StNA1 and it has been suggested this type of nutrient medium could be used for running agar diffusion tests.
Bacteriologists at Globolab eV Laboratory (Assling, Germany) conducted 103 comparative tests to evaluate the growth characteristics of beta-hemolytic Streptococcus spp. on StNA1 compared to Müller–Hinton agar supplemented with 5% sheep blood (B-MH). The specimens were obtained from patients admitted to a cooperating hospital in Germany and 16 beta-hemolytic streptococci strains were obtained.
Bacteria to be tested are streaked uniformly across a culture plate. Paper disks impregnated with eight different antibiotics (Oxoid; Wesel, Germany) to be tested are placed on the surface of the gelatinous agar. During incubation of the agar plate, the antibiotics diffuse from the disks into the surrounding agar. An effective agent will inhibit bacterial growth, and the size of such a zone of inhibition (ZoI) around the disk is measured. The relative effectiveness of a compound is determined by comparing the diameter of the ZoI with values in standard tables.
The authors found that found in 99 out of 103 (96.12%) of all cases that the absolute values of ZoI differences were smaller than or equal to 3 mm, and 92 out of 103 (89.32%) were smaller than or equal to 2 mm. The Standard Nutrient Agar 1 (StNA1) is marketed by Carl Roth GmbH (Karlsruhe, Germany) can be used for culturing Enterobacteriaceae, Pseudomonas spp., Staphylococcus spp., and Streptococcus spp. The B-MH used in the study was obtained from bioMérieux (Marcy l'Etoile, France).
The authors concluded that although blood agar is always the better choice for several reasons, the reading of the ZoI is often easier on StNA1 than on B-MH. This is because StNA1 is more transparent and, therefore, the edges between bacterial growth and the inhibition zone can be discerned more easily. In such places where no blood agar is available for conducting antibiograms, StNA1 is an appropriate substitute for blood-supplemented Müller–Hinton agar. The study was published on August 29, 2012, in the European Journal of Clinical Microbiology & Infectious Diseases.
Related Links:
Globolab e.V. Laboratory
Oxoid
Carl Roth GmbH
Latest Microbiology News
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








